Anti-PLM/ FXYD1 monoclonal antibody
Anti-PLM/ FXYD1 antibody for FACS & in-vivo assay
Go to FXYD1/FXYD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0454-Ab-1/ GM-Tg-hg-MP0454-Ab-2 | Anti-Human FXYD1 monoclonal antibody | Human |
GM-Tg-rg-MP0454-Ab-1/ GM-Tg-rg-MP0454-Ab-2 | Anti-Rat FXYD1 monoclonal antibody | Rat |
GM-Tg-mg-MP0454-Ab-1/ GM-Tg-mg-MP0454-Ab-2 | Anti-Mouse FXYD1 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0454-Ab-1/ GM-Tg-cynog-MP0454-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FXYD1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0454-Ab-1/ GM-Tg-felg-MP0454-Ab-2 | Anti-Feline FXYD1 monoclonal antibody | Feline |
GM-Tg-cang-MP0454-Ab-1/ GM-Tg-cang-MP0454-Ab-2 | Anti-Canine FXYD1 monoclonal antibody | Canine |
GM-Tg-bovg-MP0454-Ab-1/ GM-Tg-bovg-MP0454-Ab-2 | Anti-Bovine FXYD1 monoclonal antibody | Bovine |
GM-Tg-equg-MP0454-Ab-1/ GM-Tg-equg-MP0454-Ab-2 | Anti-Equine FXYD1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0454-Ab-1/ GM-Tg-hg-MP0454-Ab-2; GM-Tg-rg-MP0454-Ab-1/ GM-Tg-rg-MP0454-Ab-2; GM-Tg-mg-MP0454-Ab-1/ GM-Tg-mg-MP0454-Ab-2; GM-Tg-cynog-MP0454-Ab-1/ GM-Tg-cynog-MP0454-Ab-2; GM-Tg-felg-MP0454-Ab-1/ GM-Tg-felg-MP0454-Ab-2; GM-Tg-cang-MP0454-Ab-1/ GM-Tg-cang-MP0454-Ab-2; GM-Tg-bovg-MP0454-Ab-1/ GM-Tg-bovg-MP0454-Ab-2; GM-Tg-equg-MP0454-Ab-1/ GM-Tg-equg-MP0454-Ab-2 |
Products Name | Anti-FXYD1 monoclonal antibody |
Format | mab |
Target Name | FXYD1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-FXYD1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species PLM/ FXYD1 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLP002101 | human FXYD1 Lentivirus plasmid |
ORF Viral Vector | vGMLP002101 | human FXYD1 Lentivirus particle |
ORF Viral Vector | pGMLPm000088 | mouse Fxyd1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm000088 | mouse Fxyd1 Lentivirus particle |
Target information
Target ID | GM-MP0454 |
Target Name | FXYD1 |
Gene ID | 5348,56188,58971,721628,476487,105261259,616139,100630886 |
Gene Symbol and Synonyms | 0610012C17Rik,1110006M24Rik,FXYD1,PLM,Pml |
Uniprot Accession | O00168,O08589,P56513,Q3SZX0 |
Uniprot Entry Name | PLM_HUMAN,PLM_RAT,PLM_CANLF,PLM_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000266964 |
Target Classification | N/A |
The target: FXYD1, gene name: FXYD1, also named as PLM. This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. The protein encoded by this gene is a plasma membrane substrate for several kinases, including protein kinase A, protein kinase C, NIMA kinase, and myotonic dystrophy kinase. It is thought to form an ion channel or regulate ion channel activity. Transcript variants with different 5' UTR sequences have been described in the literature. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.